Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?

被引：70

作者：

Fauser, BCJM

Devroey, P

机构：

[1] Univ Utrecht, Ctr Med, Dept Reprod Med, NL-3508 GA Utrecht, Netherlands

[2] Dutch Speaking Free Univ Brussels, Ctr Reprod Med, Brussels, Belgium

来源：

FERTILITY AND STERILITY | 2005年 / 83卷 / 06期

关键词：

D O I：

10.1016/j.fertnstert.2005.02.011

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The use of GnRH antagonist rather than agonist cotreatment during ovarian hyperstimulation for IVF is not widely accepted. Possible benefits, current shortcomings, and avenues for future development are discussed. (c) 2005 by American Society for Reproductive Medicine.

引用

收藏

页码：1607 / 1611

页数：5

相关论文

共 29 条

[1] Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial [J].

Aboulghar, MA ;

Mansour, RT ;

Serour, GI ;

Al-Inany, HG ;

Amin, YM ;

Aboulghar, MM .

REPRODUCTIVE BIOMEDICINE ONLINE, 2004, 8 (05) :524-527

[2] GnRH antagonist in assisted reproduction: a Cochrane review [J].

Al-Inany, H ;

Aboulghar, M .

HUMAN REPRODUCTION, 2002, 17 (04) :874-885

[3] Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation [J].

Albano, C ;

Smitz, J ;

Camus, M ;

RiethmullerWinzen, H ;

VanSteirteghem, A ;

Devroey, P .

FERTILITY AND STERILITY, 1997, 67 (05) :917-922

[4]

[Anonymous], 1998, Hum Reprod, V13, P3023

[5] Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment [J].

Beckers, NGM ;

Macklon, NS ;

Eijkemans, MJ ;

Ludwig, M ;

Felberbaum, RE ;

Diedrich, K ;

Bustion, S ;

Loumaye, E ;

Fauser, BCJM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09) :4186-4192

[6] Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome [J].

Bosch, E ;

Valencia, W ;

Escudero, E ;

Crespo, J ;

Simón, C ;

Remohi, J ;

Pellicer, A .

FERTILITY AND STERILITY, 2003, 80 (06) :1444-1449

[7] Gonadotropin-releasing hormone antagonist: new tools vs. old habits [J].

Bouchard, P ;

Fauser, BCJM .

FERTILITY AND STERILITY, 2000, 73 (01) :18-20

[8] Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles:: a prospective randomized study [J].

Cédrin-Durnerin, I ;

Grange-Dujardin, D ;

Laffy, A ;

Parneix, I ;

Massin, N ;

Galey, J ;

Théron, L ;

Wolf, JP ;

Conord, C ;

Clément, P ;

Jayot, S ;

Hugues, JN .

HUMAN REPRODUCTION, 2004, 19 (09) :1979-1984

[9] Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review [J].

Delvigne, A ;

Rozenberg, S .

HUMAN REPRODUCTION UPDATE, 2002, 8 (06) :559-577

[10] Reproductive biology and IVF: ovarian stimulation and endometrial receptivity [J].

Devroey, P ;

Bourgain, C ;

Macklon, NS ;

Fauser, BCJM .

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (02) :84-90